NIHR Newcastle Biomedical Research Centre, Newcastle University, Newcastle upon Tyne, UK
NIHR Clinical Research Network Cluster E, Newcastle University, Newcastle upon Tyne, Tyne and Wear, UK.
BMJ Open. 2020 Nov 5;10(11):e043634. doi: 10.1136/bmjopen-2020-043634.
To provide guidance to researchers, funders, regulators and study delivery teams to ensure that research on COVID-19 is inclusive, particularly of groups disproportionately affected by COVID-19 and who may have been historically under-served by research.
Groups who are disproportionately affected by COVID-19 include (but are not limited to) older people, people with multiple long-term conditions, people with disabilities, people from Black, Asian and Ethnic minority groups, people living with obesity, people who are socioeconomically deprived and people living in care homes. All these groups are under-served by clinical research, and there is an urgent need to rectify this if COVID-19 research is to deliver relevant evidence for these groups who are most in need. We provide a framework and checklists for addressing key issues when designing and delivering inclusive COVID-19 research, based on the National Institute for Health Research INnovations in CLinical trial design and delivery for the UnDEr-served project roadmap. Strong community engagement, codevelopment and prioritisation of research questions and interventions are essential. Under-served groups should be represented on funding panels and ethics committees, who should insist on the removal of barriers to participation. Exclusion criteria should be kept to a minimum; intervention delivery and outcome measurement should be simple, flexible and tailored to the needs of different groups, and local advice on the best way to reach and engage with under-served communities should be taken by study delivery teams. Data on characteristics that allow identification of under-served groups must be collected, analyses should include these data to enable subgroup comparisons and results should be shared with under-served groups at an early stage.
Inclusive COVID-19 research is a necessity, not a luxury, if research is to benefit all the communities it seeks to serve. It requires close engagement with under-served groups and attention to aspects of study topic, design, delivery, analysis and dissemination across the research life cycle.
为研究人员、资助者、监管者和研究实施团队提供指导,以确保 COVID-19 研究具有包容性,特别是针对那些受 COVID-19 影响不成比例的群体,以及那些历史上研究服务不足的群体。
受 COVID-19 影响不成比例的群体包括(但不限于)老年人、患有多种慢性疾病的人、残疾人、来自黑人和少数民族群体的人、肥胖人群、社会经济贫困人群以及居住在护理院的人。所有这些群体在临床研究中都得不到充分服务,如果 COVID-19 研究要为最需要的这些群体提供相关证据,就迫切需要纠正这一问题。我们根据国家卫生研究院 INnovations in CLinical trial design and delivery for the UnDEr-served 项目路线图,提供了一个框架和检查表,用于解决设计和实施包容性 COVID-19 研究中的关键问题。强有力的社区参与、共同制定和优先考虑研究问题和干预措施至关重要。服务不足的群体应在资助小组和伦理委员会中有代表,他们应坚持消除参与障碍。应尽量减少排除标准;干预措施的实施和结果测量应简单、灵活,并针对不同群体的需求进行调整,研究实施团队应征求当地有关如何接触和吸引服务不足社区的最佳建议。必须收集能够识别服务不足群体特征的数据,分析应包括这些数据,以便能够进行亚组比较,并在早期阶段与服务不足群体分享研究结果。
如果研究要使它所服务的所有社区受益,包容性 COVID-19 研究是必要的,而不是奢侈品。这需要与服务不足的群体密切合作,并关注研究生命周期中的研究主题、设计、实施、分析和传播等方面。